Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)

China · Delayed Price · Currency is CNY

6.14

+0.01 (0.16%)

Mar 20, 2026, 11:45 AM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Industry	1.47B	1.59B	1.12B	1.10B	908.01M
Industry Growth	-7.52%	42.49%	1.58%	21.07%	-36.01%
Unallocated Other	1.90M	3.03M	2.25M	1.29M	-
Unallocated Other Growth	-37.25%	34.59%	73.95%	-	-
Total	1.47B	1.59B	1.12B	1.10B	908.01M
Total Growth	-7.57%	42.47%	1.66%	21.21%	-36.01%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	1.47B	1.59B	1.12B	1.10B	908.01M
China Growth	-7.57%	42.47%	1.66%	21.21%	-36.01%
Total	1.47B	1.59B	1.12B	1.10B	908.01M
Total Growth	-7.57%	42.47%	1.66%	21.21%	-36.01%

Source: S&P Global Market Intelligence.